Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3800
-0.0474 (-11.09%)
At close: Nov 20, 2025, 4:00 PM EST
0.3890
+0.0090 (2.37%)
Pre-market: Nov 21, 2025, 6:45 AM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $22.82 million as of November 21, 2025. Its market cap has decreased by -48.21% in one year.
Market Cap
22.82M
Enterprise Value
15.88M
1-Year Change
-48.21%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $22.82M, a decrease of -65.42%. That is a compound annual growth rate of -35.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 25.67M | -3.43% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |